KOR

e-Article

Diagnosis and management of tumor lysis syndrome.
Document Type
article
Source
Journal of Community Hospital Internal Medicine Perspectives, Vol 10, Iss 3, Pp 269-272 (2020)
Subject
tumor lysis syndrome
cancer
tumor
uric acid
malignancy
Internal medicine
RC31-1245
Language
English
ISSN
2000-9666
20009666
Abstract
Tumor lysis syndrome (TLS) is an oncological emergency characterized by a classic tetrad of hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia. Risk assessment and prophylactic therapy is critical in preventing this oncological emergency. Treatment of established TLS involves aggressive hydration, electrolyte management, and the use of hypouricemic agents.